A detailed history of Deutsche Bank Ag\ transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 42,463 shares of TNDM stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,463
Previous 33,649 26.19%
Holding current value
$1.53 Million
Previous $1.36 Million 32.84%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$35.21 - $47.3 $310,340 - $416,902
8,814 Added 26.19%
42,463 $1.8 Million
Q2 2024

Aug 14, 2024

BUY
$30.43 - $53.43 $730,320 - $1.28 Million
24,000 Added 248.73%
33,649 $1.36 Million
Q1 2024

May 15, 2024

SELL
$22.09 - $35.41 $821,438 - $1.32 Million
-37,186 Reduced 79.4%
9,649 $341,000
Q4 2023

Feb 14, 2024

BUY
$14.28 - $31.03 $603,658 - $1.31 Million
42,273 Added 926.63%
46,835 $1.39 Million
Q3 2023

Nov 09, 2023

SELL
$19.33 - $36.22 $1.09 Million - $2.03 Million
-56,137 Reduced 92.48%
4,562 $94,000
Q2 2023

Aug 14, 2023

BUY
$24.18 - $42.46 $552,996 - $971,060
22,870 Added 60.46%
60,699 $1.49 Million
Q1 2023

May 15, 2023

SELL
$35.86 - $46.5 $1.92 Million - $2.49 Million
-53,582 Reduced 58.62%
37,829 $1.54 Million
Q4 2022

Feb 13, 2023

BUY
$35.49 - $56.15 $676,936 - $1.07 Million
19,074 Added 26.37%
91,411 $4.11 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $68.97 $609,489 - $960,614
-13,928 Reduced 16.15%
72,337 $3.46 Million
Q2 2022

Aug 11, 2022

BUY
$53.22 - $123.09 $1.31 Million - $3.04 Million
24,659 Added 40.03%
86,265 $5.11 Million
Q1 2022

May 13, 2022

SELL
$101.89 - $150.09 $4.18 Million - $6.16 Million
-41,073 Reduced 40.0%
61,606 $7.16 Million
Q4 2021

Feb 11, 2022

SELL
$118.18 - $153.21 $5.16 Million - $6.69 Million
-43,651 Reduced 29.83%
102,679 $15.5 Million
Q3 2021

Nov 04, 2021

BUY
$93.51 - $129.4 $2.03 Million - $2.8 Million
21,659 Added 17.37%
146,330 $17.5 Million
Q2 2021

Aug 11, 2021

SELL
$77.0 - $100.19 $3.07 Million - $3.99 Million
-39,827 Reduced 24.21%
124,671 $12.1 Million
Q1 2021

May 13, 2021

BUY
$81.28 - $104.34 $7.6 Million - $9.76 Million
93,515 Added 131.74%
164,498 $14.5 Million
Q4 2020

Feb 16, 2021

SELL
$86.4 - $121.75 $6.46 Million - $9.11 Million
-74,825 Reduced 51.32%
70,983 $6.79 Million
Q3 2020

Nov 12, 2020

BUY
$95.43 - $116.09 $7.49 Million - $9.12 Million
78,535 Added 116.74%
145,808 $16.6 Million
Q2 2020

Aug 13, 2020

BUY
$60.05 - $98.92 $56,026 - $92,292
933 Added 1.41%
67,273 $6.66 Million
Q1 2020

May 14, 2020

SELL
$47.37 - $90.04 $18.4 Million - $34.9 Million
-387,990 Reduced 85.4%
66,340 $4.27 Million
Q4 2019

Feb 14, 2020

BUY
$53.13 - $71.19 $18.8 Million - $25.2 Million
353,636 Added 351.2%
454,330 $27.1 Million
Q3 2019

Nov 14, 2019

SELL
$57.11 - $73.3 $20.5 Million - $26.3 Million
-359,368 Reduced 78.11%
100,694 $5.94 Million
Q2 2019

Aug 14, 2019

SELL
$54.41 - $71.7 $937,103 - $1.23 Million
-17,223 Reduced 3.61%
460,062 $29.7 Million
Q1 2019

May 15, 2019

SELL
$32.25 - $73.56 $18.1 Million - $41.2 Million
-560,410 Reduced 54.01%
477,285 $30.3 Million
Q4 2018

Feb 14, 2019

BUY
$28.45 - $40.65 $12.2 Million - $17.4 Million
427,454 Added 70.05%
1,037,695 $39.4 Million
Q3 2018

Dec 21, 2021

BUY
$21.39 - $51.17 $3.41 Million - $8.15 Million
159,230 Added 35.31%
610,241 $26.1 Million
Q3 2018

Nov 14, 2018

BUY
$21.39 - $51.17 $5.78 Million - $13.8 Million
270,185 Added 149.42%
451,011 $19.3 Million
Q2 2018

Apr 21, 2020

BUY
$4.9 - $23.64 $70,961 - $342,354
14,482 Added 8.71%
180,826 $3.98 Million
Q2 2018

Aug 14, 2018

BUY
$4.9 - $23.64 $193,305 - $932,598
39,450 Added 31.09%
166,344 $3.66 Million
Q1 2018

May 15, 2018

BUY
$2.35 - $4.96 $297,947 - $628,858
126,786 Added 117394.44%
126,894 $628,000
Q4 2017

Feb 14, 2018

BUY
$2.24 - $8.2 $241 - $885
108
108 $0

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.31B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.